naproxen has been researched along with vatalanib in 1 studies
Studies (naproxen) | Trials (naproxen) | Recent Studies (post-2010) (naproxen) | Studies (vatalanib) | Trials (vatalanib) | Recent Studies (post-2010) (vatalanib) |
---|---|---|---|---|---|
4,551 | 1,057 | 1,429 | 276 | 42 | 98 |
Protein | Taxonomy | naproxen (IC50) | vatalanib (IC50) |
---|---|---|---|
Bile salt export pump | Homo sapiens (human) | 10 | |
Epidermal growth factor receptor | Homo sapiens (human) | 0.4577 | |
Platelet-derived growth factor receptor beta | Homo sapiens (human) | 0.2013 | |
Mast/stem cell growth factor receptor Kit | Homo sapiens (human) | 0.73 | |
Vascular endothelial growth factor receptor 1 | Homo sapiens (human) | 0.1192 | |
Vascular endothelial growth factor receptor 3 | Homo sapiens (human) | 0.1475 | |
Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 0.378 | |
Vascular endothelial growth factor receptor 2 | Danio rerio (zebrafish) | 0.49 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
1 other study(ies) available for naproxen and vatalanib
Article | Year |
---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |